Incidence of Lower Limb Lymphedema in Post therapeutic Gynaecological Malignancies

Raghava Krishna Sakkuru; Narendra Hulikal; Subramanian Bala Venkata; Madhavi Konetigari

doi:10.15621/ijphy/2023/v10i2/1322

Authors

Raghava Krishna Sakkuru Tutor, College of Physiotherapy, SVIMS, Tirupati, Andhra Pradesh, 517502.
Narendra Hulikal Professor & HOD, Department of Surgical Oncology, SVIMS, Tirupati, Andhra Pradesh, 517502. E-mail: drnarendrah@yahoo.co.in
Subramanian Bala Venkata Associate Professor & HOD, Department of Radiotherapy, SVIMS, Tirupati, Andhra Pradesh, 517502.
Madhavi Konetigari Principal, College of Physiotherapy, SVIMS, Tirupati, Andhra Pradesh, 517502.

DOI:

https://doi.org/10.15621/ijphy/2023/v10i2/1322

Keywords:

Gynaecological malignancy, Bio-impedance analyzer, lowers limb lymphedema, incidence, extracellular fluid, limb circumference.

Abstract

Introduction: Lower limb lymphedema (LLL) is one of the most disabling side effects of surgical and radiotherapy treatment for gynecological cancers (carcinoma of the cervix, carcinoma of the ovary, carcinoma of the endometrium, and carcinoma of the vulva). The incidence of lymphedema varies in gynecological cancers and patients undergoing radiotherapy and surgery. This prospective study aims to determine the incidence of lower limb lymphedema after surgery and radiotherapy in gynecological malignancies.
Methodology: A total of 512 subjects who undergo treatment for gynecological malignancies in the department of surgical oncology and / or radiotherapy were screened to find out the incidence of lymphedema by measuring limb circumference with inch tape and extracellular fluid (ECF) volume with bio-impedance analyzer at four intervals, before surgery/ radiotherapy, after surgery/radiotherapy, three months follow-up and six months follow-up. The limb circumference and ECF were used to find out the lymphedema.
Results: Turkey's pairwise comparison test was carried out to determine the incidence of lymphedema in both subjects (radiotherapy & surgery). The percentage of incidence of lymphedema in subjects who have undergone radiotherapy and surgical treatment with gynecological malignancies is 18.94% overall.
Conclusion: Many subjects developed lymphedema with post-treatment gynecological malignancies. It causes significant functional problems, emotional disturbances, adversely affecting the quality of life, and it also causes a financial burden to the family. Lymphedema can be diagnosed initially using a Bio-impedance analyzer and inch tape to minimize the complications and progression of the disease.

References

Maryovitz HN. The standard of care for lymphedema: current concepts and physiological considerations. Lymphat ResBio, 2009.

Mitra D, Catalano PJ, Cimbak N et al. The risk of lymphedema after postoperative radiation therapy in endometrial. J Gynecol Oncol. 2016; 27:4.

Beesley V, Janda M, Eakin E et al. Lymphedema after gynaecological cancer treatment: Cancer. 2007; 109, 2607-14.

Khalid N, Dharmarajan A, Sateeshan B et al. The incidence and risk factors for development of lower limb lymphedema after treatment for gynaecological cancers. Int J Reprod Contracept Obstet Gynecol. 2018: 7: 1168-1172.

Barakat R. Lymphedema after surgery in patients with endometrial cancer, cervical cancer, or vulvar cancer. Clinical Trials.gov Identifier: NCT00956670.

Hareyama H, Hada K, Goto K. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynaecologic malignancies: a retrospective study. Int J Gynecol Cancer. 2015; 25,751-7.

Biglia N, Zanfagnin V, Daniele A et al. Lower Body Lymphedema in Patients with Gynecologic Cancer. Anticancer Res. 2017; 37, 4005-4015.

Lindqvist E, Wedin M, Fredrikson M et al. Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2017; 211: 112-121..

Hopp EE, Osborne JL, Schneider DK et al. A prospective pilot study on the incidence of post-operative lymphedema in women with endometrial cancer. Gynecol Oncol Rep. 2016; 15: 25-8.

Tada H, Teramukai S, Fukushima M and Sasaki H. Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma. BMC Cancer. 2009; 9: 47.

O'Donnell Jr .TF, Rasmussen JC and Servic -Muraca EM. New Diagnostic Modalities In The Evaluation Of Lymphedema. J Vasc Venous Lymphat Disord. 2017: 5: 261-273.

Okeke AA, Bates DO and Gillatt BH. Lymphedema in urological cancer. EuropeAn Urology. 2004: 45: 18-25.

Szuba A and Rockson SG. Lymphedema: Classification, diagnosis and a. therapy. Vascular medicine. 1998; 3:145-156.

Warren A G, Janz B A, Slavin S A Borud L J. The use of bioimpedence analysis to evaluate lymphedema. Annals of plastic surgery: 2007; 58, 541-543.